statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Latest Ratings for HOWL
 DateFirmActionFromTo Nov 2021SVB LeerinkMaintainsOutperform Sep 2021B of A SecuritiesInitiates Coverage OnBuy May 2021Evercore ISI GroupInitiates Coverage OnOutperform...

The Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 Experts

JMP Securities started coverage on shares of Werewolf Therapeutics (NASDAQ:HOWL - Free Report) in a research note published on Wednesday, Marketbeat.com reports. The firm issued a mkt outperform...

Werewolf Therapeutics (NASDAQ:HOWL) Research Coverage Started at JMP Securities

WTX-518, a conditionally activated IL-18 INDUKINETM molecule that resists suppression by IL-18BP, led to complete tumor regressions in preclinical models WTX-712, a conditionally activated IL-21...

Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting

PREDATOR protein engineering technology allows for the expansion of INDUKINE molecules beyond oncology targets into new applications across a range of immunology targets, including inflammatory...

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR  Platform in Immunology-Based Diseases at AAI Annual Meeting

Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 432,000 shares...

Short Interest in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Drops By 7.1%

For the last three days, A.I.dvisor has detected that HOWL's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Werewolf Therapeutics (HOWL, $6.38) Aroon Indicator entered a Downtrend on April 01, 2024.

Werewolf Therapeutics (HOWL, $6.48) Aroon Indicator entered a Downtrend on March 28, 2024.

Werewolf Therapeutics (HOWL, $6.33) Aroon Indicator entered a Downtrend on March 27, 2024.

Werewolf Therapeutics (HOWL, $6.04) Aroon Indicator entered a Downtrend on March 26, 2024.

Additional monotherapy dose-escalation data from ongoing Phase 1/1b clinical trial of WTX-124 expected to be presented in the first half of 2024 WTX-124 recommended dose for expansion (RDE...

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.

Watchers	637
52-Wk Low	$1.57
52-Wk High	$8.19

Volume	91,420.00
52-Wk High	$8.19
52-Wk Low	$1.57

HOWL Werewolf Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals